Previous studies have revealed that circRNA-coded micropeptide AKT3-174aa, FBXW7-185aa, SHPRH-146aa, and PINT-87aa might be independent prognostic indicators and therapeutic targets in GBM [38]. The gene discussed is AKT3; the disease is glioblastoma.